UPLD:NASDAQUpland Software, Inc. Analysis
Data as of 2026-06-01 - not real-time
$0.90
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Upland Software (UPLD) trades around $0.90, well below its 20‑day SMA of $0.80 and far beneath the 30‑day DCF fair value of $9.61, indicating a massive valuation gap. The stock shows a bullish MACD crossover and an RSI of 60, suggesting modest upward momentum, yet the overall trend remains neutral and the price sits above short‑term support ($0.526) but below long‑term resistance ($1.06). Recent news highlights a new CEO taking the helm and a Q1 loss of $1.2 million, with revenue down 23.5% YoY and guidance slightly missing estimates, underscoring ongoing execution challenges.
Despite weak margins, negative earnings, and a high debt‑to‑equity ratio, the extreme upside potential (over 300% to fair value) and the “Extreme Greed” market sentiment create a speculative opportunity. However, volatility is elevated at 146% over 30 days and beta exceeds 1.8, pointing to pronounced price swings and liquidity concerns.
Despite weak margins, negative earnings, and a high debt‑to‑equity ratio, the extreme upside potential (over 300% to fair value) and the “Extreme Greed” market sentiment create a speculative opportunity. However, volatility is elevated at 146% over 30 days and beta exceeds 1.8, pointing to pronounced price swings and liquidity concerns.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bullish MACD but price below long‑term SMA200
- Recent revenue decline and Q1 loss
- Decreasing volume indicating waning liquidity
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- DCF fair value suggests >300% upside
- New CEO and AI‑focused product roadmap
- Potential stabilization of cash flow despite current losses
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Deep valuation discount relative to industry PE average
- Secular demand for cloud‑based knowledge management software
- Opportunity to restructure balance sheet and improve margins
Key Metrics & Analysis
Financial Health
Revenue Growth-23.50%
Profit Margin-7.07%
P/E Ratio1.2
ROE-17.31%
ROA3.05%
Debt/Equity294.50
P/B Ratio-0.5
Op. Cash Flow$23.1M
Free Cash Flow$36.5M
Industry P/E41.9
Technical Analysis
TrendNeutral
RSI60.0
Support$0.53
Resistance$1.06
MA 20$0.80
MA 50$0.71
MA 200$1.51
MACDBullish
VolumeDecreasing
Fear & Greed Index93.11
Valuation
Fair Value$9.61
Target Price$3.75
Upside/Downside315.28%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.85
Volatility146.55%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.